01/02/2019 Physiogenex to present at the NASH-TAG 2019
Physiogenex will present at the NASH-TAG 2019 in Park City, UT, USA, January 3rd-5th, 2019.
Dr. François Briand, Director of Research and Business Development, will be presenting one poster dealing with Physiogenex NASH animal models, and a second poster dealing with the measurement of alpha-SMA protein levels in NASH/fibrosis models, using a HTRF assay kit developed by Cisbio.
If you wish to set-up an appointment with Dr. François Briand to discuss about your preclinical NASH projects, please contact us.
Physiogenex is a leading preclinical research organization providing non clinical services in metabolic disorders and complications. We offer in vivo translational diseases models as well as ex vivo assays to support efficacy and pharmacological assays. We focus on metabolic diseases, diabetes, insulin resistance, obesity, dyslipidemia, liver diseases (NASH to fibrosis) and renal complications.
Please visit our website for more information